127 related articles for article (PubMed ID: 12485492)
1. [The effect of multi-unit ribozymes on the growth inhibition and apoptosis induction of CML K562 cells].
Feng Q; Sun B; Sun K; Shang Z; Wang S; Wang W; Zhao Y; Yan Z; Han W; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):435-9. PubMed ID: 12485492
[TBL] [Abstract][Full Text] [Related]
2. [Study on the in vitro cleavage abilities of ribozymes specific to different sites of bcr-abl fusion gene and their induction of apoptosis in K562 cells].
Feng Q; Sun B; Zhao Y
Zhonghua Yi Xue Za Zhi; 2000 Feb; 80(2):127-30. PubMed ID: 11798747
[TBL] [Abstract][Full Text] [Related]
3. [Construction of retrovirus vector of bcr/abl mRNA cleaving ribozyme gene and its effects on K562 cells].
Wu Y; Chen Y; Hu J
Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):623-6. PubMed ID: 11263328
[TBL] [Abstract][Full Text] [Related]
4. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
[TBL] [Abstract][Full Text] [Related]
5. Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization.
Mendoza-Maldonado R; Zentilin L; Fanin R; Giacca M
Cancer Gene Ther; 2002 Jan; 9(1):71-86. PubMed ID: 11916246
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of RNA interference on chronic myeloid leukemia bcr/abl oncogene expression].
Ma XX; Wang C; Wei J; Qin YW; Yan SK; Gao YR; Cai Q
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):359-62. PubMed ID: 16185484
[TBL] [Abstract][Full Text] [Related]
7. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ
Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic effect of As2S2 on K562 cells and its mechanism.
Li JE; Wu WL; Wang ZY; Sun GL
Acta Pharmacol Sin; 2002 Nov; 23(11):991-6. PubMed ID: 12421474
[TBL] [Abstract][Full Text] [Related]
9. [The effect of anti-bcr-abl hammerhead ribozyme on bone marrow purging].
Wu Y; Chen YZ; Huang HF; Chen P; Lu LH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Sep; 35(9):859-63. PubMed ID: 12958661
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for BCR-ABL+ human CML with dual phosphorylation resistant p27Kip1 and stable RNA interference using an EBV vector.
Sengupta A; Banerjee D; Chandra S; Banerjee S
J Gene Med; 2006 Oct; 8(10):1251-61. PubMed ID: 16952195
[TBL] [Abstract][Full Text] [Related]
11. Cleavage of BCR/ABL mRNA by synthetic ribozymes--effects on the proliferation rate of K562 cells.
Lange W
Klin Padiatr; 1995; 207(4):222-4. PubMed ID: 7564157
[TBL] [Abstract][Full Text] [Related]
12. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
Wang W; DU Y; Lin GQ; Li NN; Sun BZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
[TBL] [Abstract][Full Text] [Related]
13. Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice.
Ruan GR; Liu YR; Chen SS; Fu JY; Chang Y; Qin YZ; Li JL; Yu H; Wang H
Leuk Res; 2004 Jul; 28(7):763-9. PubMed ID: 15158098
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
15. [Different sensitivity of two chronic myeloid leukemia cell lines to interferon-alpha].
Li XM; Chen HC; Liu XF; Wu YH; Cao YF
Ai Zheng; 2003 Oct; 22(10):1047-52. PubMed ID: 14558948
[TBL] [Abstract][Full Text] [Related]
16. [Apoptosis of K562 cells induced by antisense-oligonucleotides of CRKL gene].
Wang S; Sun BZ; Yu WQ; Zhang T; Feng Q; Shang ZC
Ai Zheng; 2002 Sep; 21(9):934-8. PubMed ID: 12508536
[TBL] [Abstract][Full Text] [Related]
17. [Effects of anti-ABL tyrosine kinase intrabody on the growth of K562 cells in nude mice].
Xu D; Song JM; Hu Y; Guo H; Cao DJ; Wang P; Liu H; Zhao CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):11-4. PubMed ID: 12905832
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNA.
Lange W; Cantin EM; Finke J; Dölken G
Leukemia; 1993 Nov; 7(11):1786-94. PubMed ID: 8231247
[TBL] [Abstract][Full Text] [Related]
19. [Experimental study on the role of VEGF autocrine loop in K562 leukemia cells].
Xu WL; Shen HL; Yuan W; Jiang YW; Wu ZY; Fei X; Tang HR
Zhonghua Xue Ye Xue Za Zhi; 2007 Mar; 28(3):189-93. PubMed ID: 17649713
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study of K562 cell apoptosis induced by siRNA].
Chen BB; Fan HH; Lin GW; Yuan ZH; Lu HZ; Gao L; Liu Y
Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):717-9. PubMed ID: 15730712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
